Rakha et al. found that MUC3 was expressed in 91% of invasive breast cancer samples and that its expression was significantly associated with the lymph node stage, a poor Nottingham prognostic index (NPI), a high grade, and an increased risk of local recurrence [41]. This evidence concerns the gene MUC3A and invasive breast carcinoma.